4.7 Article

Analysis of Select Dietary Supplement Products Marketed to Support or Boost the Immune System

期刊

JAMA NETWORK OPEN
卷 5, 期 8, 页码 -

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamanetworkopen.2022.26040

关键词

-

资金

  1. Consortium for Health and Military Performance and Operation Supplement Safety [HU0001-18-2-0099]

向作者/读者索取更多资源

The sales of cold, flu, and immunity dietary supplement products have surged during the COVID-19 pandemic. This study examined 30 selected products marketed as immune system support and found that most of them had inaccurate labels and misleading claims.
IMPORTANCE Cold, flu, and immunity dietary supplement product sales have skyrocketed since the start of the COVID-19 pandemic. Supporting or boosting the immune system has become an important reason for using dietary supplements, and many consumers are purchasing products through online platforms. OBJECTIVES To examine whether select dietary supplement products advertised as supporting or boosting the immune system are accurately labeled according to the Supplement Facts label of listed ingredients and to qualitatively describe the product labels' characteristics in terms of claims made. DESIGN, SETTING, AND PARTICIPANTS In this case series, 30 featured immune health dietary supplements were selected and purchased from Amazon.com in May 2021. Product analysis was performed using liquid chromatography-mass spectrometry. The list of ingredients detected through analysis for each product was compared with the ingredients on the product's Supplement Facts label to determine whether the product's label was accurate. Claims made on product labels were also evaluated by using the Operation Supplement Safety Scorecard's set of questions to describe the labels' characteristics. RESULTS A total of 30 select dietary supplement products were evaluated. Thirteen of the 30 products had accurate labels based on the product analysis. Of the 17 products with inaccurate labels, 13 had ingredients listed on the labels that were not detected through analysis, such that their labels were misbranded. Nine products had substances detected that were not claimed on the product labels, some of which may be considered adulterated. Five were misbranded and contained additional components not claimed on the label. No product had third-party certification seals present on the packaging. Ten of the 13 products with accurate labels received a score of 4 or more when applying the Operation Supplement Safety Scorecard, meaning the product was likely okay/less risky. CONCLUSIONS AND RELEVANCE In this case series study, most of the products tested had inaccurate labels and claims that were inconsistent with requirements the US Food and Drug Administration has put forward for dietary supplements. Quality control measures seem to be insufficient for most of these select products, and claims made on labels may be misleading consumers who purchase products.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据